Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Samuel N. Breit, David A. Brown, Vicky Wang-Wei Tsai
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 127-151
Closed Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

GDF15 promotes weight loss by enhancing energy expenditure in muscle
Dongdong Wang, Logan K. Townsend, Geneviève J. DesOrmeaux, et al.
Nature (2023) Vol. 619, Iss. 7968, pp. 143-150
Open Access | Times Cited: 114
Mitochondrial stress and mitokines in aging
Johannes Burtscher, Afsaneh Soltany, Nishant P. Visavadiya, et al.
Aging Cell (2023) Vol. 22, Iss. 2
Open Access | Times Cited: 57
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 274-286.e10
Open Access | Times Cited: 52
GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
Ja Young Kim-Muller, LouJin Song, Brianna LaCarubba Paulhus, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111947-111947
Open Access | Times Cited: 52
Ponsegromab for the Treatment of Cancer Cachexia
John D. Groarke, Jeffrey Crawford, Susie M. Collins, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 40
GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice
K. Fichtner, Hermann Kalwa, Miaomiao Lin, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 734-734
Open Access | Times Cited: 16
Atlas of the plasma proteome in health and disease in 53,026 adults
Yue‐Ting Deng, Jia You, Yu He, et al.
Cell (2024)
Open Access | Times Cited: 16
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study
Luca Monzo, Constance Xhaard, João Pedro Ferreira, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 5
The Role of GDF15 as a Myomitokine
Kornelia Johann, Maximilian Kleinert, Susanne Klaus
Cells (2021) Vol. 10, Iss. 11, pp. 2990-2990
Open Access | Times Cited: 81
Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15
Irène Cimino, Hanna Kim, Y. C. Loraine Tung, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 27
Open Access | Times Cited: 71
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway
Wanli Zhang, Weikuan Sun, Xiaofan Gu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 41
Overview of growth differentiation factor 15 in metabolic syndrome
Mohamed Asrih, Shibo Wei, Thanh Thuy Nguyen, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 9, pp. 1157-1167
Open Access | Times Cited: 29
Growth differentiation factor 15 (GDF-15) in endocrinology
Pedro Iglesias, Ramona A. Silvestre, Juan J. Díez
Endocrine (2023) Vol. 81, Iss. 3, pp. 419-431
Closed Access | Times Cited: 23
Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease
Balázs Bence Nyárády, Loretta Kiss, Zsolt Bagyura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116475-116475
Open Access | Times Cited: 13
Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Jian Li, Xiangjun Hu, Zichuan Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116809-116809
Open Access | Times Cited: 13
Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, “futile” fatty acid cycling, and FADH2 oxidation
Roman Abrosimov, Marius W. Baeken, Samuel Hauf, et al.
GeroScience (2024) Vol. 46, Iss. 4, pp. 3635-3658
Open Access | Times Cited: 12
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design
John D. Groarke, Jeffrey Crawford, Susie M. Collins, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 3, pp. 1054-1061
Open Access | Times Cited: 11
The Metabolic Basis of Cancer-Related Fatigue
Robert Dantzer, Brandon Chelette, Elisabeth G. Vichaya, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106035-106035
Closed Access | Times Cited: 1
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Douglas P. Loesch, Manik Garg, Dorota Matelska, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
A growth factor–expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15
Andreas Patsalos, László Halász, Miguel A. Medina-Serpas, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 1
Open Access | Times Cited: 54
Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity
Darakhshan Sohail Ahmed, Stéphane Isnard, Carolina Berini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
RET receptor signaling: Function in development, metabolic disease, and cancer
Masahide Takahashi
Proceedings of the Japan Academy Series B (2022) Vol. 98, Iss. 3, pp. 112-125
Open Access | Times Cited: 35
Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
Marlena S. Fejzo, Kimber MacGibbon, Olivia First, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2022) Vol. 129, Iss. 11, pp. 1845-1852
Open Access | Times Cited: 32
Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
David Aguilar-Recarte, Emma Barroso, Xavier Palomer, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 741-754
Closed Access | Times Cited: 28
GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing
Yang Wan, Jianhua Fu
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 3, pp. 453-466
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top